Belpointe Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,011
| Closed | -$641K | – | 1010 |
|
|
2025
Q1 | $641K | Sell |
1,011
-959
| -49% | -$608K | 0.03% | 480 |
|
|
2024
Q4 | $2.34M | Buy |
1,970
+127
| +7% | +$151K | 0.14% | 148 |
|
|
2024
Q3 | $1.94M | Buy |
1,843
+54
| +3% | +$56.8K | 0.12% | 177 |
|
|
2024
Q2 | $1.88M | Buy |
1,789
+475
| +36% | +$500K | 0.13% | 149 |
|
|
2024
Q1 | $1.26M | Buy |
1,314
+985
| +299% | +$948K | 0.09% | 210 |
|
|
2023
Q4 | $289K | Sell |
329
-483
| -59% | -$424K | 0.03% | 535 |
|
|
2023
Q3 | $668K | Buy |
812
+439
| +118% | +$361K | 0.07% | 268 |
|
|
2023
Q2 | $268K | Sell |
373
-669
| -64% | -$481K | 0.03% | 498 |
|
|
2023
Q1 | $856K | Sell |
1,042
-61
| -6% | -$50.1K | 0.05% | 376 |
|
|
2022
Q4 | $796K | Sell |
1,103
-150
| -12% | -$108K | 0.05% | 384 |
|
|
2022
Q3 | $863K | Buy |
1,253
+604
| +93% | +$416K | 0.06% | 337 |
|
|
2022
Q2 | $384K | Sell |
649
-4
| -0.6% | -$2.37K | 0.03% | 592 |
|
|
2022
Q1 | $456K | Sell |
653
-1,122
| -63% | -$784K | 0.03% | 566 |
|
|
2021
Q4 | $1.12M | Sell |
1,775
-3,525
| -67% | -$2.23M | 0.07% | 287 |
|
|
2021
Q3 | $3.21M | Buy |
5,300
+2,842
| +116% | +$1.72M | 0.22% | 93 |
|
|
2021
Q2 | $1.37M | Sell |
2,458
-2,043
| -45% | -$1.14M | 0.1% | 225 |
|
|
2021
Q1 | $1.93M | Buy |
4,501
+4,080
| +969% | +$1.75M | 0.17% | 135 |
|
|
2020
Q4 | $203K | Buy |
421
+2
| +0.5% | +$964 | 0.02% | 687 |
|
|
2020
Q3 | $235K | Sell |
419
-624
| -60% | -$350K | 0.03% | 511 |
|
|
2020
Q2 | $650K | Sell |
1,043
-15
| -1% | -$9.35K | 0.08% | 246 |
|
|
2020
Q1 | $517K | Sell |
1,058
-486
| -31% | -$237K | 0.09% | 238 |
|
|
2019
Q4 | $580K | Buy |
+1,544
| New | +$580K | 0.07% | 294 |
|